2025 ISPE Aseptic Conference

The pharmaceutical industry is undergoing a remarkable transformation, with advanced modalities like antibody-drug conjugates (ADCs) and radiopharmaceuticals driving the evolution of precision medicine. These innovations are not only redefining drug development but are also improving patient outcomes through targeted therapies, reduced side effects, and expanded treatment options. The integration of these next-generation modalities introduces unique challenges in manufacturing, regulatory compliance, and operational efficiency—but also immense opportunities for advancing healthcare.

The 2025 ISPE Aseptic Conference, taking place 17 – 18 March 2025 in Washington, D.C., USA, has always been one of the more future-focused technical conferences within ISPE. Originally called the ISPE Barrier Conference, its emphasis lies on the procedures and technology of restricted access barrier systems (RABS) and isolators.

Advanced therapy medicinal products (ATMPs) are medicines based on genes, tissues, or cells. This class of products cannot be terminally sterilized and, in many cases, cannot be filtered and are manufactured by Aseptic processing. The increase in demand for these life-changing products has been fraught with technical and regulatory challenges as laboratory processes are scaled to commercial manufacturing. As an industry, we need to address ATMP resiliency in its many forms. The 2025 ISPE Aseptic Conference Committee is proud to present the track ATMPs. This track will showcase case studies of manufacturing resiliency and technical presentations addressing lessons learned from manufacturing ATMPs.